Immix Biopharma, Inc. (IMMX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $104.84M | +356.9% |
| 2024 | $22.95M | +15.2% |
| 2023 | $19.93M | +33.7% |
| 2022 | $14.91M | -18.1% |
| 2021 | $18.19M | +3271.4% |
| 2020 | $539.6K | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $104.84M | +356.9% |
| 2024 | $22.95M | +15.2% |
| 2023 | $19.93M | +33.7% |
| 2022 | $14.91M | -18.1% |
| 2021 | $18.19M | +3271.4% |
| 2020 | $539.6K | — |